EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients

Kishan Majithiya iD, Komal Singh, Pankti Mehta iD, Chengappa Kavadichanda iD, M S Gayathri iD, Deepika Kounassegarane, Ranjan Gupta iD, Seema Sharma, Able Lawrence iD, Amita Aggarwal iD

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70243 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Kishan Majithiya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology & Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. Hauptthemen laut MEDLINE: Neutrophils, Bacterial Infections, Lupus Erythematosus, Systemic, Fever. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim and Objectives To assess the role of newer biomarkers like neutrophil Z, myeloid‐related protein 8/14 (MRP 8/14), IL‐6, sCD14, and neutrophil CD64 (nCD64) to distinguish flare from infection in febrile lupus patients.

Methods

In this prospective multicentric observational study to determine the etiology of fever in febrile lupus patients, in addition to routine tests, serum procalcitonin, neutrophil X, neutrophil Y, and neutrophil Z were done. sCD14, MRP8/14, and IL‐6 were done by ELISA. nCD64 expression was measured by flow cytometry. All these biomarkers were assessed individually and in combination to see their ability to distinguish between infection and lupus flare.

Results

Among 159 febrile SLE patients, there were 55 infections, 65 disease flares, 38 flares and infections combined, and 1 malignancy. Patients with bacterial infections had a higher CRP, procalcitonin, neutrophil‐to‐lymphocyte ratio, Neutrophil Z, sCD14 levels, and neutrophil CD64 expression. While patients with flares had lower C3, C4, and higher anti‐DsDNA antibody levels. IL‐6 and MRP8/14 levels were similar in both groups. Combination of neut‐Z with C3 or anti‐dsDNA antibody could discriminate between flare and infection with AUC 0.88 (0.80–0.96) and 0.86 (0.78–0.95). Addition of TLC or procalcitonin or nCD64 MFI to these scores improved them marginally. Though composite scores with CRP and anti‐dsDNA/procalcitonin also performed well but these were inferior to neutrophil Z‐based composite models. These results were consistent in sensitivity analysis.

Conclusion

Neutrophil Z, complement C3 , anti‐ dsDNA antibody levels, and TLC or procalcitonin‐based composite score are good tools to differentiate between infection and flare in a febrile lupus patient. Serum MRP 8/14, IL ‐6, sCD14 , and nCD64 did not perform well. Simple biomarkers such as neut‐Z should be investigated further in SLE .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsBacterial InfectionsLupus Erythematosus, SystemicFeveralpha-DefensinsHumansBiomarkersProspective StudiesFemaleMaleAdultPredictive Value of TestsDiagnosis, DifferentialMiddle AgedReceptors, IgGSymptom Flare UpCalgranulin BInterleukin-6Calgranulin AYoung AdultATP-Binding Cassette Transporters

Stichwörter der Autor:innen

anti‐dsDNA autoantibodybacterial infectionsbiomarkersinterleukin‐6neutrophil Zprocalcitoninsystemic lupus erythematosus

Substanzen

BiomarkersReceptors, IgGCalgranulin BInterleukin-6Calgranulin AABCC11 protein, humanalpha-DefensinsIL6 protein, humanATP-Binding Cassette Transporters

Autor:innen und Institutionen

  • Department of Clinical Immunology & Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
  • Department of Clinical Immunology, JIPMER, Puducherry, India.
  • Department of Rheumatology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

ORCID-Profile: Kishan Majithiya, Pankti Mehta, Chengappa Kavadichanda, M S Gayathri, Ranjan Gupta, Able Lawrence, Amita Aggarwal

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Majithiya, K., Singh, K., Mehta, P., Kavadichanda, C., Gayathri, M. S., Kounassegarane, D., Gupta, R., Sharma, S., Lawrence, A., & Aggarwal, A. (2025). Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70243

Vancouver

Majithiya K, Singh K, Mehta P, Kavadichanda C, Gayathri MS, Kounassegarane D, et al. Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70243

BibTeX
@article{Majithiya2025,
  author = {Majithiya, Kishan and Singh, Komal and Mehta, Pankti and Kavadichanda, Chengappa and Gayathri, M S and Kounassegarane, Deepika and Gupta, Ranjan and Sharma, Seema and Lawrence, Able and Aggarwal, Amita},
  title = {Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70243}
}
Kostenlos starten →